THC-dominant cannabis

Phase 2Small molecule

BBrown University

THC-dominant cannabis is one of 4 small molecule programs targeting Alcohol Consumption. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Alcohol ConsumptionRecruiting

Alcohol ConsumptionPhase 2

Recruiting

Competition

Competitive Landscape

5 competitors in Alcohol Consumption

#DrugCompanyPhaseTrials

Alcohol

Astellas

Phase 2

1 2

THC-dominant cannabis

BBrown University

Phase 2

1 3

Hezkue

AAspargo Labs, Inc

Phase 1

1 4

Mavoglurant

YYale University

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 2Recruiting

Alcohol Consumption

NCT05389930

Clinical

Trials by Indication[1]

Alcohol Consumption1 trial

Cannabis' Impact on Alcohol Consumption

Recruiting·—·Phase 2·NCT05389930·350 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for THC-dominant cannabis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — THC-dominant cannabis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for THC-dominant cannabis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Brown University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: BBrown University

THC-dominant cannabis

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Alcohol Consumption1 trial

References

Drug Info

Quick Facts

Related News